Biomea Fusion, Inc. (BMEA) vs Verrica Pharmaceuticals Inc. (VRCA)

Biomea Fusion, Inc. and Verrica Pharmaceuticals Inc. are both Biotechnology companies. Biomea Fusion, Inc. and Verrica Pharmaceuticals Inc. are of similar size ($64.9M and $60.6M). Biomea Fusion, Inc. has the higher net margin (0.00% vs −102.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Biomea Fusion, Inc. leads on 9 and Verrica Pharmaceuticals Inc. on 4.

Valuation

Metric BMEA VRCA Biotechnology median
P/E n/m n/m 8.50
P/S n/m 2.49 9.71
P/B 5.19 17.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2.56 9.21
Earnings yield (33.33%) (47.18%) (33.15%)
Free cash flow yield (74.51%) (18.02%) (25.50%)

Profitability

Metric BMEA VRCA Biotechnology median
Gross margin 0.00% 85.89% 65.16%
Operating margin 0.00% (93.59%) 0.00%
Net margin 0.00% (102.84%) 0.00%
Free cash flow margin 0.00% (44.02%) 0.00%
Return on equity (164.14%) 473.29% (56.36%)
Return on assets (59.14%) (83.02%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BMEA VRCA Biotechnology median
Revenue growth (TTM) — 106.21% 6.02%
EPS growth (last fiscal year) 69.19% 88.65% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BMEA VRCA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 3.48 1.45 4.72
Net debt to EBITDA 0.68 2.59 0.96

Dividend

Metric BMEA VRCA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BMEA VRCA Biotechnology median
Market cap 60.62m 64.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack